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ABSTRACT: Gamma-aminobutyric acid (GABA)
has a dual role as an inhibitory neurotransmitter in the
adult central nervous system (CNS) and as a signaling
molecule exerting largely excitatory actions during
development. The rate-limiting step of GABA synthesis
is catalyzed by two glutamic acid decarboxylase isoforms
GAD65 and GAD67 coexpressed in the GABAergic neu-
rons of the CNS. Here we report that the two GADs
show virtually nonoverlapping expression patterns con-
sistent with distinct roles in the developing peripheral
olfactory system. GAD65 is expressed exclusively in
undifferentiated neuronal progenitors confined to the
proliferative zones of the sensory vomeronasal and olfac-
tory epithelia In contrast GAD67 is expressed in a subre-
gion of the nonsensory epithelium/vomeronasal organ
epithelium containing the putative Gonadotropin-releas-
ing hormone (GnRH) progenitors and GnRH neurons
migrating from this region through the frontonasal mes-
enchyme into the basal forebrain. Only GAD671, but
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not GAD651 cells accumulate detectable GABA. We
further demonstrate that GAD67 and its embryonic
splice variant embryonic GAD (EGAD) concomitant
with GnRH are dynamically regulated during GnRH
neuronal migration in vivo and in two immortalized cell
lines representing migratory (GN11) and postmigratory
(GT1–7) stage GnRH neurons, respectively. Analysis of
GAD65/67 single and double knock-out embryos
revealed that the two GADs play complementary (inhibi-
tory) roles in GnRH migration ultimately modulating
the speed and/or direction of GnRH migration. Our
results also suggest that GAD65 and GAD67/EGAD
characterized by distinct subcellular localization and
kinetics have disparate functions during olfactory system
development mediating proliferative and migratory
responses putatively through specific subcellular GABA
pools. VC 2014 Wiley Periodicals, Inc. Develop Neurobiol 00: 000–000,
2014
Keywords: GAD forms; gamma-aminobutyric acid;
GnRH; olfactory development; cell migration
INTRODUCTION
In addition to being an inhibitory neurotransmitter,
gamma-aminobutyric acid (GABA) exerts excitation
and acts as a trophic factor during development mod-
ulating many processes at the cellular and tissue level
like proliferation, neuronal migration, differentiation
and maturation (LoTurco et al., 1995; Barker et al.,
1998; Owens and Kriegstein, 2002; Ben-Ari and
Holmes, 2005).
The rate-limiting step in the synthesis of GABA is
catalyzed by two highly homologous enzyme iso-
forms of GAD—GAD65 and GAD67 that are coex-
pressed in the GABAergic inhibitory neurons of the
central nervous system (CNS) and differ by kinetic
properties and subcellular distribution (Martin et al.,
2000). Two alternatively spliced, developmentally
regulated embryonic GAD (EGAD) messages are
synthesized in the rat (Bond et al., 1990) and mouse
(Szabo et al., 1994) and code for two truncated GAD
proteins representing the N-terminal (GAD25) and
C-terminal (GAD44) portions of GAD67 (Szabo
et al., 1994). Both Gad genes are expressed from
embryonic day 9.5 (E9.5) in the mouse, prior to the
onset of GABAergic neuronal differentiation and
show a specific spatiotemporal expression profile in
the embryonic CNS and non-neuronal structures
including the peripheral olfactory system (Katarova
et al., 2000).
The development of the olfactory system in the
mouse begins at E9.5 with the induction of the olfac-
tory placodes—paired structures comprising a thick-
ening of the rostral head epithelium (Balmer and
LaMantia, 2005; Beites et al., 2005; Whitlock, 2005;
Treloar et al., 2010; Wray, 2010) and proceeds
through a highly coordinated sequence of events
leading to formation of the olfactory pit, nasal epithe-
lia, and olfactory bulb. During this period, the olfac-
tory–vomeronasal epithelia go through different
stages of elaborate folding within the frontonasal
mesenchyme (FNM) concomitant with the generation
of several neuronal lineages: the sensory neurons
residing in the olfactory epithelium (OE) and vomer-
onasal epithelium (VNE), as well as different types
of migratory neurons including the GnRH neurons
(Treloar et al., 2010). The generation of different epi-
thelia and neuronal cell types is thought to occur in a
series of epithelial–mesenchymal (E/M) induction
events regulated initially by retinoic acid (RA),
which is expressed locally in the neural crest-derived
mesenchyme underlying the olfactory placodes
(Balmer and LaMantia, 2005) and the olfactory pit
epithelium (Kawauchi et al., 2004). Three different
types of neurons—olfactory and vomeronasal recep-
tor neurons (ORN and VRN, respectively) and GnRH
neurons—are born around the placodal stage (E9.5)
and later (E10.5) become confined to different, par-
tially overlapping domains of the olfactory pit epithe-
lium that are defined by the expression of
transcription factors known to regulate neural differ-
entiation like Pax6, Sox2, Mash1, and neurogenin 1
(Ngn1) as well as fibroblast growth factor 8 (Fgf8;
Beites et al., 2009; Rawson et al., 2010).
It has been shown that the GnRH neurons migrate
out of the olfactory placode-derived vomeronasal
organ (VNO) along the vomeronasal nerve (VNN)
through the septum toward their final destination
located in the septal-preoptic area of the ventral
hypothalamus (Schwanzel-Fukuda and Pfaff, 1989;
Wray et al., 1989; Mulrenin et al., 1999; Whitlock,
2005; Tobet and Schwarting, 2006; Wray, 2010;
Wierman et al., 2011). The adult GnRH neurons pro-
ject to the median eminence and release GnRH pep-
tide into the hypophyseal portal system and—by
stimulating the production and secretion of follicle
stimulating hormone and luteinizing hormone—regu-
late the functions of the gonads, sexual development
and reproduction (Wierman et al., 2011).
The GnRH neuronal migration is modulated by
numerous factors like adhesion molecules, axonal
guidance cues, neurotransmitters, neuropeptides, and
growth factors that influence cell-surface attachment
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and migration characteristics, such as speed and
direction (Tobet and Schwarting, 2006; Cariboni
et al., 2007; Cariboni et al., 2011; Cariboni et al.,
2012; Messina and Giacobini, 2013). GABA has
been shown to be present, presumably transiently in
migratory GnRH neurons (Tobet et al., 1996;
Fueshko et al., 1998a; Lee et al., 2008) and to inhibit
the rate of GnRH neuronal migration in a paracrine
fashion via GABA(A) receptor (GABA(A)R) activa-
tion in vitro (Fueshko et al., 1998b). Similarly, in
vivo treatment of pregnant dams with the GABA(A)R
agonist muscimol inhibits GnRH neuronal migration
out of the nasal cavity and their fiber extension to the
median eminence (Bless et al., 2000). In contrast,
bicuculline (GABA(A)R antagonist) treatment results
in dispersion of GnRH neurons within the brain due
to dissociation of GnRH neurons from their guiding
fibers leading to the suggestion that GABA acting on
GABA(A)R modulates cell adhesion molecules and
thereby the association of GnRH neurons with VNN
axons (Bless et al., 2000). Indeed, a variety of adhe-
sion molecules are involved in the regulation of the
GnRH neuronal migration and their absence results
in disorganized or impaired migration and conse-
quently disruption of proper sexual development and
reproductive cycle (Kottler et al., 2004; Tobet and
Schwarting, 2006; Schwarting et al., 2007; Wray,
2010; Zhang et al., 2010; Wierman et al., 2011;
Casoni et al., 2012). More recently, in vitro time-
lapse studies have demonstrated that GABA pro-
motes linear migration of the GnRH neurons out of
embryonic nasal explants from E11.5 embryos since
their movements are randomized in GAD67 knock-
out (KO) mice, in which GABA concentration is
greatly reduced (Casoni et al., 2012).
GABA also increases the synthesis of the GnRH
peptide (Fujioka et al., 2007) that is known in itself to
modulate the rate of GnRH neuronal migration through
the nasal compartment (Romanelli et al., 2004).
Previous studies using in situ hybridization (ISH)
have shown that GAD67 is expressed in the olfactory
pit/VNO and adjacent respiratory epithelium (RE) at
stages E11.5–E16.5 mouse embryos with a low level
of staining in axons crossing the nasal septum at
E12.5, but not later stages (Wray et al., 1996; Katar-
ova et al., 2000). Forced expression of GAD67 by the
GnRH promoter in transgenic mice changes GnRH
neuron trajectory but not their speed of migration in
the brain resulting in the appearance of GnRH neu-
rons at ectopic positions and causing altered GnRH,
follicle-stimulating hormone (FSH), and luteinizing
hormone (LH) secretion, altered female estrous cycle
and reproductive function (Heger et al., 2003). In
GAD67 KO mice, GnRH neurons show altered
migration speed compared to wild type (WT), but
unchanged cell number (Lee et al., 2008).
Clearly, although the data so far show that GAD67
is expressed during GnRH neuronal migration, its
precise spatiotemporal regulation and its exact role in
this process is still obscure. Furthermore, the expres-
sion regulation and possible role(s) of the other GAD
forms: the embryonic GAD derived from the Gad1
gene (Szabo et al., 1994) and that of GAD65 in the
developing peripheral olfactory system, especially in
the development and migration of the GnRH neurons
have not been elucidated so far.
Here we show that (1) GAD65 and GAD67 display
segregated expression in the embryonic olfactory sys-
tem associated with distinct properties: GAD65 is
expressed in ORN/VRN progenitors anchored in the
proliferative layers of the VNO/OE, while GAD67 is
found in the nonsensory epithelium (NSE) of the
VNO/RE border region and in migratory GnRH neu-
rons throughout their journey; (2) GAD671 VNO
and GnRH cells but not the GAD651 VRN/ORN
progenitors accumulate GABA; (3) GAD67 and its
splice variant EGAD are dynamically regulated in
vivo and in vitro in the migrating GnRH; (4) despite
their segregated expression, the GAD forms affect
similarly, and therefore, have complementary roles in
the precision and timing of GnRH migration by mod-
ulating intercellular interactions between GnRH and
VRN/ORN axons.
METHODS
Animal use
Mice of strain FVB/Ant (Errijgers et al., 2007) housed in
the Division of Medical Gene Technology of the Institute
of Experimental Medicine were used. All experiments with
animals were conducted in compliance with NIH (NIH
Publication #85-23, 1985) and EC (86/609/EEC/2) guide-
lines and approved by in-house and national committees.
Transgenic and KO mice
Transgenic mice were derived by pronuclear microinjection
into FVB/Ant fertilized eggs following standard protocols
(Brinster et al., 1981; Costantini and Lacy, 1981). Two dif-
ferent GFP-green fluorescent protein (GAD65-GFP) trans-
genic mouse lines were used in this study. GAD65_2e/gfp
(line #30) carries a 6336 bp segment of the mouse Gad2
gene (encoding GAD65) spanning 5.1 kb of the 50-
upstream region, the first exon, first intron and a segment of
the second exon with enhanced GFP (eGFP) fused inframe
to the second exon and expressed as a fusion GAD65-eGFP
protein (Supporting Information Fig. S1B). In this line,
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GFP is expressed faithfully in the inhibitory GABAergic
neurons of the CNS (Lopez-Bendito et al., 2004) and in
non-neuronal tissues (Kwakowsky et al., 2007). The
GAD65_1e-6e/gfp transgenic mouse line #5 was derived
with a DNA construct containing additional 6.5 kb down-
stream in comparison to GAD65_2e/gfp and includes exons
1–6 with the respective introns. EGFP was fused into the
first ATG codon of GAD65 found in exon 1 (Supporting
Information Fig. S1B). Transgenic founders were identified
by real-time PCR using GFP TaqManVR assay on genomic
DNA obtained from tail biopsies. All transgenic progenies
were routinely identified by GFP fluorescence at P0–P2
(postnatal day 0–2) using GFP-MDS-96/BN light system
(BLS, Budapest, Hungary).
GAD65 KO (Yamamoto et al., 2004; Kubo et al., 2009)
and GAD67-GFP KI (Tamamaki et al., 2003) (Supporting
Information Fig. S1A) mice have been described previously
and were genotyped by genomic PCR using specific pri-
mers (Supporting Information Table S1). The phenotype of
the double GAD65/GAD67-GFP KI mice was identical to
the previously described GAD65/GAD67 double KO mice
(Ji et al., 1999) and these mice are herein referred to as
GAD65/67 double KO.
GAD65, GAD67 single, and GAD65/67 double KO
embryos were derived from pregnant dams upon mating
between single or double heterozygous mice and genotyped
using tail DNA; the day of the copulation plug was consid-
ered day 0.5 p.c. (post-coitum).
In Situ Hybridization
GAD65 and GAD67 cDNAs were subcloned into pGEM-T
Easy vector (Promega, Madison, WI), plasmids were line-
arized and run on preparative 0.8% agarose gels in Tris–
Acetate–EDTA (TAE) buffer. Linear DNA templates were
isolated using GeneJETTM Gel Extraction Kit (Fermentas
UAB, Vilnius, Lithuania). Digoxin-labeled GAD65 and
GAD67 riboprobes were synthesized using a DIG RNA
Labeling Kit (Roche Applied Science, IN) and 1 mg tem-
plate DNA/reaction.
Embryos were derived by caesarean section from timed
pregnant females, then rinsed immediately in ice-cold dieth-
ylpyrocarbonate (DEPC)-treated phosphate buffered saline
(PBS) and fixed in 4% paraformaldehyde (PFA) in PBS, pH
7.4 overnight at 4C. Following cryoprotection in graded
sucrose solutions (10% then 20% sucrose in DEPC-PBS), the
embryos were embedded in OCT (Tissue-Tek; Sakura Fine-
tek) and sectioned on a cryostat (MICROM International
GmbH, Walldorf, Germany). Sections of 20 mm thick were
collected on silane (3-aminopropyltriethoxysilane; Sigma-
Aldrich, St. Louis, MO)-subbed slides and air-dried. Slides
were washed several times in DEPC-PBS, treated with Pro-
teinase K (Sigma-Aldrich, 2 mg/mL in DEPC-PBS) for 10
min at room temperature (RT) and washed in DEPC-PBS.
Prehybridization was at RT in hybridization buffer (50%
formamide, 53 Saline-Sodium Citrate (SSC), 0.1% Tween-
20, 10 lg/mL tRNA). Hybridization with GAD65 or GAD67
riboprobes (100 ng/mL in hybridization buffer) was per-
formed in a humidified chamber at 56C overnight. The next
day sections were washed in 23 SSC-T (SSC10.1% Tween-
20), 0.23 SSC-T at 56C for 20 min and then in PBS with
0.1% Tween-20 (PBST) at RT. Following blocking in 2%
fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA) and
2 mg/mL bovine serum albumin (BSA; Sigma-Aldrich) in
PBST, alkaline phosphatase (AP)-conjugated anti-DIG IgG
(Roche, 1:4000 in 2% FBS) was applied overnight at 4C.
Sections were washed 33 10 min in PBST containing 2 mM
levamisole (Sigma-Aldrich) at RT and stained with nitro-blue
tetrasolium chloride (NBT)/5-bromo-4-chloro-30-indolyphos-
phate p-toluidine salt (BCIP) according to the protocol sup-
plied by Roche. Slides were examined under Zeiss Axioskop-
2 equipped with AxioCam HRc digital camera controlled by
AxioVision 4.6 software (Carl-Zeiss, Jena, Germany).
Immunohistochemistry
GnRH. Whenever GnRH immunohistochemistry (IHC)
was performed following ISH, the sections were washed with
PBS for 3 3 5 min at RT and blocked with 10% horse
serum—1% BSA in PBST for 1 h at RT. Subsequently sec-
tions were incubated with rabbit anti-GnRH antibody (Progen
GmbH, Heidelberg, Germany; 1:1000) in 1% BSA-PBST
overnight at 4C. The specificity of the antibody has been
verified by preadsorption with GnRH peptide (Ohlsson et al.,
2010). Biotinylated goat IgG (Vector Labs, Burlingame, CA;
1:500) diluted in PBST was applied for two hours at RT fol-
lowed either by ExtrAvidin–Horseradish peroxidase (HRP)
(Sigma-Aldrich; 1:500) or Streptavidin-Cy3 (Life Technolo-
gies; Carlsbad, CA; 1:5000) in PBS for 90 min at RT. For
HRP reaction, sections were washed in PBS and TBS (pH
7.4) and developed in 0.05 M 3,30-diaminobenzidine (DAB,
Sigma-Aldrich) with 0.001% H2O2 in TBS. Sections were
finally washed several times in PBS and coverslipped in DPX
(Sigma-Aldrich).
GABA. For GABA IHC, fixation was performed in 4%
PFA–0.1% glutaraldehyde–PBS overnight at 4C. Rabbit
polyclonal anti-GABA (Sigma-Aldrich; 1:5000), followed
by anti-rabbit biotinylated (Vector; 1:500) antibodies and
finally Streptavidin-Cy3 (Life Technologies; 1:5000) were
applied essentially as described for GnRH.
Ki-67, OMP, Peripherin, GAD65. Mouse embryos were
collected in ice-cold PBS, fixed in 4% PFA–0.1 M phos-
phate buffer (PB, pH 7.4) overnight at 4C and cryopro-
tected in 20% sucrose–PBS. Cryostat sections (20 mm)
were collected on gelatin-subbed slides and air-dried.
Blocking was in 0.5% blocking reagent (Roche) in PBST
for 1 h at RT. The rabbit polyclonal antibody Ki-67
(Abcam, Cambridge, UK; 1:1000), the monoclonal
GAD65-specific antibody GAD-6 (see below), goat anti-
olfactory marker protein (OMP) serum (Monti-Graziadei
et al., 1977; Farbman and Margolis, 1980; Margolis, 1982),
or rabbit anti-peripherin (Merck Millipore Billerica, MA;
1:500) were applied in 1% BSA-PBST overnight at 4C.
Following several washes in PBST, anti-rabbit Alexa 594-
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conjugated or anti-goat Alexa 488-conjugated secondary
antibodies (Life Technologies) were applied for 1 h at RT.
Slides were washed in PBST and mounted in Mowiol (Cal-
biochem, San Diego, CA) containing DABCO (1,4-diazabi-
cyclo[2.2.2]octane; Sigma-Aldrich; 0.1 mg/mL).
Whole-Mount IHC of Mouse Embryos
The GAD65-specific mouse monoclonal antibody GAD-6
developed by Gottlieb et al. (1986) was obtained from the
Developmental Studies Hybridoma Bank developed under
the auspices of the NICHD and maintained by The Univer-
sity of Iowa, Department of Biology, Iowa City, IA 52242.
Rabbit serum #6799 was previously characterized (Katar-
ova et al., 1990). Mouse embryos stages E9.5 and E10.5
were derived as described above and fixed overnight at 4C
in 4% PFA–0.05% picric acid–0.1 M PB, pH 7.4 with gen-
tle rocking, followed by 3 3 30 min washes in PBS and
TBS. Blocking was for 2 h at RT with 0.5% blocking rea-
gent (Roche) in TBS containing either 0.02% saponin (for
GAD-6) or 0.1% Triton X-100 (6799; both from Sigma-
Aldrich) followed by incubation with primary antibodies
diluted in 1% BSA-tris-buffered saline 10.05% tween-20
(TBST) for 48 h at 4C. The embryos were washed 4 3 30
min in TBST, then incubated with anti-rabbit (mouse)-
Alexa 594 in 1% BSA-TBST overnight at 4C, washed
extensively in TBST and photographed under Zeiss
LUMAR fluorescent stereomicroscope equipped with Axio-
Cam MR camera (Carl Zeiss).
Cell Culture and Immunocytochemistry
The immortalized, GnRH-expressing cell lines GN-11 and
GT1–7 were generously provided by Roberto Maggi (Insti-
tute of Endocrinology, University of Milan, Milano, Italy).
Cells were routinely grown as monolayers in Dulbeco’s
Modified Eagle’s Medium (DMEM) (Invitrogen) supple-
mented with 10% FBS, 4500 mg/L glucose, 1 mmol/L
sodium pyruvate, and 2 mmol/L L-glutamine as previously
described (Maggi et al., 2000; Lentini et al., 2008).
For immunocytochemistry, cells were seeded onto glass
coverslips in 24-well plates and grown for 24–48 h, then
rinsed with PBS and immediately fixed with either 4% PFA
or 4% PFA–0.1% glutaraldehyde for GABA staining for 20
min at RT, followed by 3 3 5 min washes in PBS. For GAD
and GnRH immunocytochemistry, cells were permeabilized
with 0.2% Triton-X100 for 5 min at RT and blocked for 1 h
at RT in 5% normal goat serum-PBST. Primary antibodies
were applied as follows: mouse anti-GAD65 clone GAD-6 at
1:250; rabbit polyclonal sera #6799 (anti-GAD67; 1:500) and
#8878 (anti-GAD44; 1:500); (Szabo et al., 1994); or rabbit
anti-GnRH (1:1000, Progen) overnight at 4C. Coverslips
were washed 3 3 10 min at RT in PBST then anti-rabbit or
anti-mouse biotinylated IgG (1:500; both from Vector) was
applied for 90 min at RT. After 3 3 10 min washes in PBST
coverslips were incubated with ExtrAvidin-HRP (1:500,
Sigma-Aldrich) for 1 h at RT, washed 3 3 10 min in PBS, 1
3 5 min in TBS, and reacted with 0.3 mg/mL DAB (Sigma-
Aldrich) in TBS, in the presence of 0.001% H2O2. Staining
for GABA was performed as follows: blocking in 10% nor-
mal horse serum, 1% BSA in PBST for 30 min at RT fol-
lowed by incubation with rabbit anti-GABA antibody
(Sigma, 1:5000) overnight at 4C, 3 3 10 min washes in
PBST and incubation with secondary and tertiary antibodies
as described for GAD antibodies.
RNA Preparation and RT-PCR
Transgenic Embryos. Cell biopsies were dissected along
the migratory route of GnRH neurons from sections obtained
from GAD65_1e-6e/gfp E13.5 embryos then fixed in 0.4%
PFA–DEPC-treated PBS overnight at 4C with gentle rock-
ing. After cryoprotection in 20% sucrose, in DEPC-treated
PBS, series of 25-mm-sagittal sections were cut on a cryostat,
mounted on silane-subbed slides and briefly dried at RT.
GFP1 cell groups from the VNO or GnRH neuronal migra-
tory route were identified under Zeiss LUMAR fluorescent
stereomicroscope (Carl Zeiss) and isolated manually as dem-
onstrated schematically in Figure 6(A). Total RNA was pre-
pared using the NucleoSpinVR RNA XS (Macherey-Nagel,
D€uren, Germany) kit and reverse transcribed using Super-
Script III First-Strand Synthesis System for RT-PCR (Life
Technologies). Amplification parameters and primers were as
outlined in Supporting Information Table S2: denaturation at
94C for 5 min, followed by 35 cycles of 94C for 45 s;
annealing at 59.8C (GAD65); 62C (GAD67); 65C
(GnRH) for 45 s, extension at 72C for 10 min. In some
experiments, nested PCR was performed using primers listed
in Supporting Information Table S2.
Cultured Cell Lines and Unfixed Tissue. Total RNA
from brain or GN-11 or GT1–7 cell lines was isolated using
TRI-Reagent (Sigma-Aldrich) according to the manufac-
turer’s protocol. Three micrograms of RNA were reverse-
transcribed using RevertAidTM H Minus First Strand cDNA
Synthesis Kit (Fermentas) with random hexamer primers
according to the manufacturer’s instructions. PCR amplifi-
cation was performed with specific primers and cycle con-
ditions outlined in Supporting Information Table S2, with
final extension at 72C for 10 min. b-actin was coamplified
as control for 16–20 cycles either in the same tube or sepa-
rately at identical conditions.
GnRH1 Cell Number Estimation in WT
and KO Mouse Embryos
The number and spatial distribution of GnRH neurons was
investigated in GAD65 and GAD67 KO and WT embryos at
ages of E12.5 and E14.5. Three embryos were analyzed in
each experimental group. GnRH IHC was performed as
described above. Every GnRH1 neuron was counted in each
consecutive sagittal section within two compartments: (1) the
nasal septum and (2) the nasal–forebrain junction (NFJ). The
number of cells per region and total cell number were esti-
mated for each animal as the average of counted cells.
The distribution of GnRH1 neuronal clusters along the
VNN and NFJ was obtained by counting all GnRH1 cell
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profiles within a migratory group (cohort) along the VNN
in E13.5 double GAD KO and WT embryos (n5 3). The
cumulative size probability of GnRH1 cohorts was calcu-
lated and plotted for their visual representation. We defined
a cohort as a group of migrating GnRH neurons with seem-
ingly adjacent cell bodies.
The spatial distribution of the migratory GnRH1 neu-
rons was obtained by 3D reconstruction using a computer-
assisted morphometry system consisting of a Zeiss Axio-
skop 2 mot microscope equipped with an MS-88 two axis
computer-controlled stepping motor system and a DV-47d
color digital camera assisted by Neurolucida and Neuro-
Explorer software (MBF Bioscience, Williston, VT). All
GnRH1 neurons were traced for reconstruction. Datasets
of pair-matched adjacent sections were then exported to
NeuroExplorer to generate 3D reconstructions of the GnRH
neuronal migratory pathway.
RESULTS
Expression of GAD65 and GAD67 mRNAs
in the Frontonasal Region of Mouse
Embryos
GAD65 and GAD67 at E9.5–E10.5. Using whole-
mount IHC we were unable to detect GAD65 in the
olfactory placodes at stage E9.5, the earliest stage of
peripheral olfactory system development [Fig. 1(A)].
In contrast, strong expression signal over the olfac-
tory placode area with a faint staining in the underly-
ing mesenchyme of GAD67 was observed [Fig.
1(B)]. At E10.5, weak GAD65 staining was detected
over the rim of the lateral aspect of the olfactory pit
invagination [Fig. 1(C)]. Sections for the same-age
embryo hybridized with GAD65 antisense RNA
revealed staining of the central olfactory pit epithe-
lium as well. At this stage, GAD67 showed a much
stronger expression in the rim of the olfactory pit and
a diffuse staining in the underlying mesenchyme; the
anterior (facial) surface ectoderm was also strongly
labeled [Fig. 1(D)].
GAD65 (E13.5–E15.5). Our previous studies showed
that GAD65 mRNA is detectable at E11.5 in the
forming VNO/olfactory pit, but is absent from the
nasal region of E12.5 embryo (Katarova et al., 2000).
Here we have performed GAD65 DIG-ISH on series
of sections from E13.5 and E15.5 mouse embryos,
which demonstrated that at E13.5, GAD65 is
expressed exclusively in the sensory epithelium of
the VNO and OE [Fig. 2(B-D)]. No signal was
observed over the nonsensory RE [Fig. 2(B)]. The
hybridization signal at stage E13.5 was overall weak
and visibly enriched over the basal and apical layers
in both OE and VNO, although labeled cells were
also detected scattered in the thickness of the epithe-
lium. At E15.5 and later stages the hybridization sig-
nal became much stronger and shifted to basal layer
expression in both OE and VNO [Fig. 2(A, E–I)]. A
characteristic feature of the GAD65 expression pat-
tern in the OE is the conspicuous patches comprised
cell clusters interrupted by regions of low or no
expression [Fig. 2(G, H)].
At these stages of development, the OE is a pseu-
dostratified neuroepithelium that comprises cells
positioned in pseudolayers as basal and apical pseu-
dolayers containing proliferating globose basal
(GBC) and supporting (sustentacular) cells, respec-
tively, and the middle pseudolayer containing differ-
entiating ORNs (Carson et al., 2006; Treloar et al.,
2010) [Fig. 3(D)]. At E11–E14, the majority of divid-
ing cells are found apically in the OE, while later in
development proliferation occurs predominantly near
the base of the OE (Rosenbaum et al., 2011). The
ORNs differentiate from the self-renewing GBCs,
which give rise to transit-amplifying achaete-scute
homolog 1 (Mash 1) and neurogenin 1 (Ngn1)-
expressing INPs that differentiate into postmitotic
ORNs identified by staining for OMP (Margolis,
1982).
Figure 1 Expression of GAD65 and GAD67 in the fronto-
nasal region of E9.5–E10.5 embryos: whole mount indirect
immunofluorescence. (A, C) Staining with the anti-GAD65
antibody GAD-6. (B, D) staining was performed with anti-
GAD67 serum #6799. Arrow in (B): strong staining of the
olfactory placode. Arrows in (C, D) point to the partially
overlapping expression in the olfactory pit labeled by
GAD65 (C) or GAD67 (D) with the latter producing a
much stronger signal. (*) marks the strong GAD65 signal
in the tailbud.
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The GAD65 mRNA-expressing cells of the OE
and VNO confine to the basal/apical layers at E13.5–
E14.5 [Figs. 2 and 3(A)] or the basal layer alone at
E15.5 and later stages (Fig. 2 and data not shown),
which contain cells undergoing active proliferation
(Carson et al., 2006; Beites et al., 2009; Tucker et al.,
2010; Rosenbaum et al., 2011). Hence, we applied an
antibody raised against the proliferation marker Ki-
67, which delineates the borders of the proliferative
zones (Rosenbaum et al., 2011). We found that at
E14.5 GAD651 cells codistribute with the Ki-671
mitotically active progenitors to the basal/apical epithe-
lial layers [Fig 3(A, B and scheme in D)], while at
stages E15.5 or later, GAD65 was found exclusively in
the basal layer containing undifferentiated ORN pre-
cursors only, the apical layer containing Ki-671 sus-
tentacular cell progenitors (Rosenbaum et al., 2011)
was devoid of GAD65 signal (Fig. 2). However, only a
subpopulation of GAD651 cells of the basal layer
appeared to be mitotically active and expressed Ki-67
(Supporting information Fig. S2). Postmitotic ORNs of
the intermediate layer identified with an anti-OMP anti-
body (Keller and Margolis, 1975) [Fig. 3(C,D)] do not
stain for GAD65 at any stage [compare to (A)].
Using of GAD65 ISH on sections from GAD65-
GFP transgenic mice expressing GFP in immature
and differentiated ORN and some post-mitotic pro-
genitors, we detected GAD65 and GFP colocalization
exclusively in the previously described GAD651
cell clusters of the basal layers of VNO and OE con-
taining rounded undifferentiated cells, but not in
elongating cells with morphological features of
differentiating neurons (Supporting Information
Fig. S3).
GAD67 (E11.5–E15.5). Strong expression of GAD67
during E11.5–12.5 was detected in the ventral aspect
of the olfactory pit, the forming VNO and an area of
RE continuous with the VNO (Katarova et al., 2000).
[Fig. 4(A–B)]. This pattern was preserved also at
later stages [E13.5–E15.5; Fig. 4(D, K)]. In addition,
GAD67 was also prominently expressed in a popula-
tion of migratory cells in the nasal septum migrating
by adhering to the olfactory (vomeronasal) nerve that
Figure 2 GAD65 expression in the developing nasal region of mouse embryos: ISH on sagittal
sections. GAD65 gene is expressed in the olfactory epithelium (OE) and vomeronasal organ (VNO)
of E13.5 (B–D) and E15.5 (A; E–I) mouse embryos. GAD65 expression is confined to the basal
(arrowheads in B, C) and apical (arrows in B, C) layers of E13.5 OE and mostly to the basal layer
(arrowheads in E, F, H) of E15.5 OE. In the VNO of E13.5, GAD65 is partially enriched (D, arrow-
heads), while at E15.5, it is confined exclusively to the basal layer (I, arrowheads). Within the OE,
GAD65 signal was often found in vertical cell columns (F–H, arrowheads). No signal is detected
over the respiratory epithelium (RE) (B, E). The lumen of the olfactory canal is marked with an
asterisk. Boxed areas in B, E, and G are shown enlarged in C, F, and H, respectively. Scale bars:
100 mm. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.
com.]
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by location and appearance resemble the migratory
GnRH neurons (Tobet et al., 1996) [Fig. 4(K–M)].
This observation was verified by a combined GAD67
ISH—GnRH IHC, which demonstrated an extensive
overlapping between GAD67 and GnRH expression
in the FNM [Fig. 4(I–J)]. Migratory neurons coex-
pressing GAD67 mRNA and GnRH peptide were
found in both the nasal septum [Fig. 4(I, J, N)] and
NFJ [Fig. 4(N), inset]. Along this route, some neu-
rons expressed either GnRH peptide or GAD67 alone
[Fig. 4(N-inset, O)]. Staining with anti-GABA anti-
body revealed accumulation of the neurotransmitter
in a region of the ventral VNO distinguished by
GAD67 ISH [Fig. 4(D)] and chain-migrating neurons
staining for GnRH [Fig. 4(E, F)].
We also investigated the expression of GFP in
GAD67-GFP KI (knock-in) embryos [Fig. 4(C, G,
H)]. In this mutant mouse line, GFP is under regula-
tion from the endogenous GAD67 promoter; (Tama-
maki et al., 2003); targeting construct shown in
Supporting Information Figure S1A. In the brain, it
recapitulates the expression pattern of the cognate
gene (Tamamaki et al., 2003). Similarly, the GFP
expression in the VNO and adjacent NSE of E12.5–
13.5 GAD67-GFP KI embryos [Fig. 4(C, G, H)] and
in migratory cells (putative GnRH neurons) emerging
from the VNO [Fig. 4(G, H)] was highly reminiscent
to the pattern obtained by GAD67 ISH [Fig. 4(B, D,
K-inset)]. The migratory cells seen in the vicinity of
VNO were only weakly labeled by GFP at E13.5
[Fig. 4(G)] and barely, if at all detectable beyond this
stage [Fig. 4(H)]. This early silencing of the GAD67
promoter is likely to result from disrupted epigenetic
regulation caused by the GFP insertion.
GFP Provides an Useful Marker for
Migratory GnRH1 Neurons in GAD65-
GFP Transgenic Mice
Transgenic GAD65-GFP mice carrying fusion genes
between GFP and the regulatory region of GAD65
were derived with two different constructs
GAD65_1e-6e/gfp and GAD65_2e/gfp carrying dif-
ferent portions of the Gad2 gene (Supporting Infor-
mation Fig. S1B; Methods). The two lines exhibited
almost identical patterns of expression in the nasal
region, but differed substantially in the forebrain
Figure 3 GAD65 is confined to the proliferative basal/apical layers of the OE. Right panels repre-
sent enlargements of the boxed areas in the left panels. Coronal sections from E14.5 embryos were
processed for: (A) GAD65 ISH; (B) Immunofluorescence (IF) with antibody specific for the prolif-
eration marker Ki-67 (a-Ki-67); (C) IF with the anti-olfactory marker protein (OMP) goat serum
(a-OMP #255), a marker for postmitotic ORN; white arrows, OMP1 postmitotic ORNs. Apical and
basal layers with borders defined by Ki67-labeled cells are marked with asterisks (A, B). (D) Sche-
matic presentation of the cell type distribution in the E14.5 olfactory epithelium: proliferating cells
(PC; in red) are confined to the apical and basal layer, respectively; postmitotic olfactory receptor
neurons (ORN; in green) occupy the intermediate layer. Scale bars: 100 mm. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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(FB): in GAD65_2e/gfp GFP strongly labeled the
GABAergic neurons of the FB, whereas GAD65_1e-
6e/gfp lacked expression in this region during late
embryonic and early postnatal stages. Unlike the
CNS, where the two lines showed correct expression
pattern (Lopez-Bendito et al., 2004; data not shown)
the GFP expression in the nasal compartment of
GAD65-GFP transgenic mouse lines is ectopic and
herein was used mainly for providing a strong fluo-
rescent label for GnRH neurons.
Examination of histological sections from E12.5–
P21 GAD65_1e-6e/gfp mice revealed that GFP-
labeled cells migrating out of the VNO in a pattern
highly reminiscent of the migratory GnRH neurons
(Fig. 5; Supporting Information Fig. S4). Staining
with an anti-GnRH antibody showed an extensive
(more than 90%) overlap between GFP and GnRH
(Fig. 5). From E12.5 on, migratory GFP1/GnRH1
cells were observed in the lamina propria of the nasal
septum [Fig. 5(A, B, E)], crossing the cribriform
Figure 4 GAD67 expression in the nasal region of mouse embryos: relation to GABA and GnRH.
(A, B, D, and K–M) ISH with GAD67 antisense probe; (F) IHC with a rabbit anti-GnRH antibody;
(E) IF staining with anti-GABA antibody; (I, J, N, and O) GAD67 ISH-GnRH IHC; (C, G, and H)
GFP fluorescence. At stages E11.5–E12.5, GAD67 and GFP in GAD67–GFP KI is expressed in the
ventral region spanning the respiratory epithelium (RE)–vomeronasal organ (VNO) border (region
above asterisk in A, B, and C, respectively). At E13.5–E14.5, GAD67 mRNA and GABA are
detected in the ventral aspect of the VNO (labeled region above asterisk in D, E, G, H, and K) and
in cell clusters migrating from this region in the FNM (G, H, white arrowheads; L, M, empty
arrows), which also express GABA (E, short white arrows) and GnRH (F, short black arrows).
Note, that on the territory of the VNO in only single migratory cells are stained for GnRH (F, black
arrowheads), the GAD67/GABA-stained region marked by asterisk in (D, E) remains unstained.
Lines in (M) delineate the bundle of VNN visualized by DIC (differential interference contrast)
microscopy. GAD671 cells migrating along the VNN at E13.5–E15.5 stain in the cytoplasm for
GnRH (thin arrows in J, N). Few migratory cells stain exclusively for GnRH (thick arrows in J, N)
or GAD67 (short empty arrows in N). (J) is an enlargement of the boxed area in (I). (K) the boxed
area is shown enlarged in the lower panel. Inset in (N) is an enlargement of the boxed area and
shows a cell cluster of migratory mostly GnRH1/GAD671 cells at the nasal–FB junction (NFJ) of
a E15.5 embryo. ns, nasal septum; Scale bars: 100 mm (A–D, F, and H) and 20 mm (E). [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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Figure 5 Migratory GnRH neurons in GAD65_1e-6e/gfp mouse embryos coexpress GFP. (A–H) Transgenic mouse line
GAD65_1e-6e/gfp was derived with a DNA construct that contains GFP fused into the initiation codon of GAD65 found in
exon 1 (Supporting Information Fig. S1; see details in Methods). Sagittal sections from E12.5–E17.5 embryos were stained
with anti-GnRH antibody (red fluorescence) and visualized also for GFP (green fluorescence). The images overlaid in Axiovi-
sion 4.8 software demonstrate an extensive overlapping between the two stains in the selected areas along the migratory route
(marked A–H) as shown schematically on the scaled drawings for each embryonic stage.
plate to group at the NFJ [Fig. 5(F, G)]. Upon enter-
ing the FB, GFP1/GnRH1 neurons detach from the
VNN and disperse, thereafter in a fan-like shape
within the basal FB [Fig. 5(D, G)]. At E17.5 and later
stages more single-labeled neurons expressing either
GnRH or GFP were observed migrating in the ventral
FB (Fig. 5H and Supporting Information Fig. S5A–
C). At P11, the overlap between the two markers was
Figure 6 Dynamic regulation of different GAD forms during migration of GFP1/GnRH1 neu-
rons in E13.5 GAD65_1e-6e/gfp embryos. (A1) Tissue punches were isolated under fluorescent
microscope from the VNO (circled in A1) and GFP1 cells of the GnRH1 migratory route (MIGR;
boxed areas in A1) were dissected from lightly fixed frozen sagittal sections from E13.5
GAD65_1e-6e/gfp embryos. (A2) RT-PCR performed with RNA isolated from punches taken from
the VNO and migratory GnRH/GFP1 cells (MIGR) as shown in (A1) and E13.5 mouse brain
(MB). GAD65 is amplified exclusively from the VNO, but not in (MIGR); GAD67 is detected in
migratory GFP1/GnRH1 cells (MIGR), but not in the VNO, while EGAD and GnRH is detected
in both with a higher expression in MIGR. Actin was amplified as control. (B) Schematic presenta-
tion of the mouse GAD protein forms encoded by different mRNAs: Gad1 codes for three mRNAs
(GAD67, I-80, and I-86) and protein forms (GAD67, GAD25, and GAD44) through alternative
splicing and coupled-translation (Szabo et al., 1994; Varju et al., 2001); here only the bicistronic I–
80 (termed for simplicity EGAD) coding for GAD25 and GAD44 is shown. Gad2 encodes a single
GAD65 mRNA and protein. The initiation codons for all GAD forms are indicated a well as the
positions of the primers used for RT-PCR . (C) RT-PCR performed with RNA isolated from
unfixed nasal septum (NS) and hindbrain (HINDB) of E13.5 GAD65_1e-6e/gfp embryos. GnRH is
expressed in the NS, but not HINDB, while all GAD forms are expressed in NS and HINDB,
respectively being more abundant in the latter, especially GAD67. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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partial albeit both GFP1 and GnRH1 profiles had
the characteristic migratory features of GnRH neu-
rons (Supporting Information Fig. S5A–C). At P21,
the most advanced stage studied, processes double
labeled for GFP/GnRH were visualized in the median
eminence (Supporting Information Fig. S5D–F), thus
GAD65_1e-6e/gfp transgenic mouse line affords an
excellent model system to analyze the GnRH neuro-
nal migration at different developmental stages and
throughout the entire migratory route without inter-
ference from other GFP1 presumed GABAergic neu-
rons of the ventral FB.
GFP1 cells of GAD65_1e-6e/gfp mouse embryos
migrate on peripherin1 axons in the FNM, (shown
for E13.5 in Supporting Information Fig. S6) as
described previously for GnRH1 neurons (Fueshko
and Wray, 1994), providing additional evidence for
their GnRH identity. Similarly, studies in transgenic
mouse lines carrying lacZ regulated by the GAD67
promoter (Katarova et al., 1998) also showed a robust
expression of bgal in the GnRH neurons migrating
along peripherin1 fibers (Katarova et al., 1998).
Using GABA IHC, we checked for the presence of
GABA in the frontonasal region of E13.5
GAD65_1e-6e/gfp transgenic embryos. A strong
GABA signal was detected in a subregion in the ven-
tral aspect of the VNO (Supporting Information Fig.
S7A–C, E–F) and migratory GFP1 neurons, which
were previously shown to express GnRH and GAD67
(see Figs. 4 and 5). A small fraction of GFP1 cells
along the migratory route were devoid of staining as
the ratio of double- and single-labeled cells was visi-
bly increased at the NFJ compared to the VNO and
FNM (Supporting Information Figs. S7H–J and S7D–
G, respectively).
Dynamic Regulation of GAD During
GnRH Neuronal Migration
Previously, we have shown that at least four different
GADs are expressed from Gad1 and Gad2 loci, as
schematically demonstrated in Figure 6(B). A single
GAD65 form is encoded by Gad2 and three major
splice variants and protein forms are synthesized
from the Gad1 locus: GAD67 protein produced from
the full-length mRNA and two truncated GAD25 and
GAD44 forms, produced by alternative splicing and
coupled translation of the bicistronic I-80/I-86 mes-
sage referred to here collectively as EGAD (Szabo
et al., 1994; Varju et al., 2001) [Fig. 6(B)].
The dynamic expression of GAD forms during
migration in GnRH neurons was further evaluated by
RT-PCR using total RNA prepared from cell biopsies
isolated from different parts of the GnRH migratory
pathway using lightly fixed tissue sections from
E13.5 GAD65_1e-6e/gfp embryos as demonstrated in
Figure 6(A1) and primers designed for specific
amplification of each GAD form (Supporting Infor-
mation Table S2 and see Materials and Varju et al.,
2002 for details). As shown previously, there is
>90% overlapping between GFP and GnRH labels
along the migratory route in this transgenic mouse
line (Fig. 5). GnRH amplified at considerably higher
levels in migratory GFP1 cells compared to VNO. A
faint GAD65-specific band was only present in the
VNO preparation, but not in the migratory neuronal
fraction in contrast to GAD67, which was detected in
migratory GFP1 neurons, but not in the VNO, in full
agreement with our ISH results. We failed to obtain
specific amplification of GAD65 in migratory neu-
rons even when using high cycle number or nested
oligonucleotide primers (data not shown). EGAD
was present at similar (low) levels in both VNO and
migratory cells. All GAD mRNAs were clearly
detected in the control sample from E13.5 mouse
brain [Fig. 6(A2)].
We also performed RT-PCR on RNA prepared
from freshly dissected unfixed nasal septum and
hindbrain of E13.5 GAD65_1e-6e/gfp embryos [Fig.
6(C)]. Hindbrain was used as control being devoid of
GnRH expression. GAD65, EGAD, and GAD67
were all detected in the nasal septum, in agreement
with our ISH data (see Figs. 2 and 4), although at a
much lower level compared to hindbrain from the
same-age embryo. As expected, GnRH was only
amplified from the septum, but not hindbrain [Fig.
6(C)]. Furthermore, GAD67 was much less abundant
than EGAD or GAD65 in the septal RNA prepara-
tions in sharp contrast to hindbrain samples [Fig.
6(C)].
The expression of GAD forms at both mRNA and
protein levels was further studied in two immortal-
ized neuronal cell lines corresponding to the NFJ
migratory (line GN11) and postmigratory (line GT1–
7) stages GnRH neurons, respectively (Maggi et al.,
2000; Fig. 7). Tissue biopsies from the respective
regions could not be used because of contaminations
from near-by local GABAergic neurons. Compared
to GN11, GT1–7 is much more aggregated and dif-
ferentiated [Fig. 7(A1–A2)]. Both lines stained for
GnRH [Fig. 7(A1–A2)]. The affinity-purified embry-
onic GAD44-specific antibody stained the cytoplasm
of GN11 cells [Fig 7(A3)], while in the more differ-
entiated GT1–7, this form was enriched in the peri-
karya and proximal cellular extensions [Fig. 7(A4)].
The GAD67-specific serum #6799 produced more
even distribution over the cell bodies [Fig. 7(A5–
A6)]. Interestingly, the GABA-specific antibody
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consistently produced stronger signals in the peri-
karya of GN11 and weaker and more diffuse staining
in GT1–7 [Fig. 7(A9–A10)]. We failed to detect
GAD65 in either GN11 or GT1–7 using two different
antibodies [Fig. 7(A7–A8)]. We next performed RT-
PCR using total RNA from GT1–7 and GN11 and
specific primers (Supporting Information Table S2)
for GAD, GnRH, as well as Dlx2&5—upstream
Figure 7 Differential regulation of different GAD forms, GnRH and Dlx2&5 in cultured GN11
and GT1–7 cells. (A) The immortalized GnRH-secreting neuronal cell lines GT11 (early migratory)
and GN1–7 (late, postmigratory) were stained with anti-GnRH antibody (A1–A2) and GAD form-
specific antibodies as follows: GAD44 (affinity purified; A3–A4); GAD67 (serum #6799; A5–A6);
GAD65 (GAD-6; A7–A8); and with an anti-GABA antibody (A9–A10). Note the absence of stain-
ing for GAD65 in both GN11 and GT1–7 (A7–A8). (B) RT-PCR using total RNA isolated from
GN11 and GT1–7 cell lines and specific primers for GnRH, GAD forms, Dlx1&2, and bIII-tubulin
as indicated in Supporting Information Table 2S; actin was amplified as control; (MB) RNA from
newborn mouse cerebellum. (C) Bar graphs representing the relative amplification of the genes
shown in (B) normalized to actin. Note the lack of expression of Dlx2 in GT1–7 and GAD65 in
both cell lines. Concurrent upregulation of GnRH, GAD67, bIII-tubulin, and Dlx5 in the more dif-
ferentiated GT1–7 in comparison to GN11. EGAD is amplified to a similar level in both cell lines,
while Dlx2 is detected at low levels only in GN11, but not in GT1–7. Scale bar in A: 10 mm. [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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Figure 8 Altered migration of the GnRH1 neurons in mutant mice carrying deletions of GAD65, GAD67, and both. (A)
Neurolucida 3D reconstruction of the GnRH migratory pathway using serial sections in the sagittal plane of E13.5 WT
embryos stained with a-GnRH antibody. Ctx, cortex; mge, medial ganglionic eminence; vno, vomeronasal organ. Each dot
represents a single GnRH1 neuron within a compartment labeled as NFJ, nasal–forebrain junction; FB, forebrain, FNM; fron-
tonasal mesenchyme. (B–D and F) Bar graphs showing the number of GnRH1 neurons in the FNM, the NFJ1FB region and
the total number of GnRH1 neurons at E12.5 or E14.5 WT, GAD652/2 and GAD672/2 embryos. A significant difference
in numbers was found between the E12.5 WT and GAD652/2 embryos at the NFJ (C, F). (E) Serial sections from E13.5
WT, GAD672/2 and GAD65/GAD672/2 KO embryos were stained for GnRH and immunoreactive cells counted in three
different regions of WT and KO embryos: FNM and NFJ1FB as shown in bar charts (A–C). (G) Cumulative frequency of
GnRH cell cohorts in GAD65/67 double KO vs. WT E13.5 embryos. The graph demonstrates the size of GnRH1 cell cohorts
(the number of cells within a migrating group) in a cumulative distribution (as described in Methods section. Note that in the
GAD65/GAD672/2 double KO mice the number as well as occurrence of larger GnRH1 cell cohorts was more frequent
compared to WT embryos both in the FNM and in the NFJ. Arrowheads in (E) point to cell GnRH1 cell cohorts in E13.5 WT
and GAD65/672/2 embryos. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
regulators of GAD (Stuhmer et al., 2002; Givens
et al., 2005) and the neuronal-specific bIII-tubulin
[Fig. 7(B,C)].
Both cell lines expressed GnRH, but the expression
level was much higher in the more differentiated
GT1–7 that also correlated with a stronger expression
of the neuronal marker bIII-tubulin and a striking 18-
fold increase of Dlx5 expression compared to GN11
[Fig. 7(B, C)]. Dlx2 was only weakly amplified from
GN11 and undetectable in GT1–7 [Fig. 7(B, C)].
GAD65 failed to be amplified in either GN11 or
GT1–7 even after 35 cycles and/or using nested pri-
mers [Fig. 7(B, C); data not shown].
EGAD (coamplified I80 and I86) was considerably
more abundant than GAD67 in GN11, while the
more differentiated postmigratory GT1–7 expressed
similar levels of the two GAD variants [Fig. 7(B, C)].
Altered Migration of GnRH Neurons
in Knockout GAD Embryos
The GnRH neuronal migration in the absence of one
or both GAD forms was assessed in GAD65 or
GAD67 KO and WT embryos. To this end, we per-
formed GnRH IHC using tissue sections from E12.5
and E14.5 GAD65KO (Kubo et al., 2009), GAD67-
GFP KI (Tamamaki et al., 2003) GAD65/67 double
KO, and WT mouse embryos (Fig. 8). The distribu-
tion of GnRH immunoreactive cells along the migra-
tory route was analyzed on consecutive series of
sagittal sections. GnRH cells were classified into: (1)
cells migrating in the region between the VNO and
lamina cribrosa (FNM); (2) between the lamina cri-
brosa and the site of entrance into the ventral FB: the
NFJ, and (3) basal FB area. The neurolucida recon-
struction of the entire GnRH migratory route in the
E13.5 embryo shown in Figure 8(A) demonstrates
that the GnRH1 cells migrate initially on branches
of the VNN in the FNM formed by VRN residing in
the VNO, cumulate eventually at the NFJ to disperse
again in the ventral FB on way to their final destina-
tion in the hypothalamic preoptic area. A smaller
group of cells migrate dorsally to the AOB as previ-
ously described (Yoshida et al., 1999).
The GnRH1 cells present in FNM and NFJ1FB
areas were counted in serial sections obtained from
different KO and WT animals and processed in paral-
lel for GnRH IHC, averaged and presented as bar
charts in Figure 8(B–D). The number of GnRH1
neurons migrating in the FNM of E12.5 GAD65 KO
embryos was slightly elevated compared to WT
[5756 50 in the KO vs. 5256 58 in the WT; Fig.
8(B)]. Significantly increased numbers were esti-
mated in the NFJ1FB compartment (2746 26 for
GAD65 KO; n5 3) compared to WT [1096 32;
n5 3, Student’s t-test p< 0.05; Fig. 8(C)]. The total
number of GnRH1 neurons in the E12.5 GAD65 KO
embryos was also increased compared to WT [Fig.
8(D)]. In addition, we encountered increased num-
bers of early migrating GnRH neurons in the region
of the NSE adjacent to the VNO of E12.5 GAD65
KO embryos (Supporting Information Fig. S7).
At E14.5, there was a moderate decrease of
GnRH1 neurons in the FNM of both GAD65 KO
(3536 153) and GAD67 KO (4396 92) compared to
control (5546 73) embryos, the effect being more
pronounced in GAD65 KO [Fig. 8(B)]. The number
of GnRH cells at the NFJ1FB at this stage was
reduced by 13–14% [8416 164 in GAD65 KO;
8346 89 in GAD67 KO versus 9396 69 in WT; Fig.
8(C)]. The difference was more pronounced in the
FNM compared to NFJ1FB compartments [Fig. 8(B,
C)]. The total number of GnRH1 neurons in WT
exceeded by 20–25% the respective numbers in
GAD67-GFP KI or GAD65 KO embryos [Fig. 8(D)].
Next, we compared the migration of GnRH1 neu-
rons in E13.5 GAD67 and double GAD65/67 KO
mutant, which contains very low levels of residual
GABA (Ji et al., 1999) with WT embryos. GnRH
IHC in both GAD67 and GAD65/67 KO embryos
demonstrated that the GnRH1 neurons were visibly
assembled in larger clusters compared to WT
throughout the whole migratory route [Fig. 8(E)].
This effect was visibly more pronounced in the dou-
ble GAD KO, therefore, we chose to perform quanti-
tative cell number analysis of the GnRH1 cell
cohorts on consecutive series of frozen sagittal sec-
tions from GAD65/67 KO and WT E13.5 mouse
embryos (n5 3) as described in Methods section.
The number of GnRH1 cells in each cohort of
migrating GnRH1 neurons for both control and KO
embryos was estimated, cell cohorts were ranked by
their sizes, then the cumulative frequencies were cal-
culated and plotted for both FNM and NFJ [Fig. 8(G,
H)]. The plots showed a significant shift in the distri-
bution of cohort size toward the bigger values in the
GAD65/67 KO embryos compared to the WT. This
difference was already apparent in the FNM, where
roughly 75% of the GnRH1 cell cohorts in the
GAD65/67 KO contained 10 cells/cohort compared
to 90% for the WT [Fig. 8(G)]. In addition, the
GnRH1 cell clusters in the FNM of the GAD65/67
double KO appeared to migrate on fewer and thicker
axonal bundles [Fig. 8(E)]. Even larger GnRH1 cell
cohorts were formed at the NFJ of GAD65/67 KO
embryos, where 65% of the cells were found in
cohorts of 10 cells/cohort, while 35% of the cohorts
belong to much larger complexes [Fig. 8(H)]. In
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comparison, over 97% of cohorts in the WT were
found in the first group [Fig. 8(H)], in support of the
notion for an enhanced aggregation of the migratory
GnRH1 in the absence of GAD/GABA. Further-
more, we found that the average number of GnRH
neurons per cohort at the NFJ of GAD65/67 KO
embryos was significantly higher compared to WT
[20.866 4.08 vs. 9.726 1.02, respectively; t-test,
p< 0.05; Fig. 8(F)].
DISCUSSION
In the CNS of rodents, the two genes responsible for
the synthesis of the neurotransmitter GABA—Gad1
and Gad2 are coexpressed from the earliest studied
embryonic stages through the adult albeit are differ-
entially regulated in the GABAergic neurons (Feld-
blum et al., 1993; Katarova et al., 2000; Varju et al.,
2001). It has been proposed that the two GAD
forms—GAD65 and GAD67—synthesize different
intracellular GABA pools (Martin and Barke, 1998;
Varju et al., 2001), the existence of which has gained
support from recent experiments (Hablitz et al.,
2009). However, the subcellular functional segrega-
tion of the two GADs in the CNS has been difficult to
tackle because of their coexpression and existence of
partial functional redundancy as well (Martin and
Barke, 1998). Expression of a single GAD form is
more common in the peripheral nervous system
(Fukushima et al., 2009; Nowak et al., 2011) and in
different non-neuronal cell types during embryonic
development, the best-described example of which is
the eye lens (Kwakowsky et al., 2007).
Previous work in the developing mouse olfactory
system has been largely focused on the role of
GABA in the migration of GnRH1 neurons, a subpo-
pulation of which accumulates the neurotransmitter
(Heger et al., 2003; Tobet and Schwarting, 2006; Lee
et al., 2008; Wray, 2010). So far no detailed study
exists on spatiotemporal expression and regulation of
the existing GAD forms. Here, for the first time we
show that the two Gad genes are differentially regu-
lated in the developing olfactory region being
expressed in a virtually nonoverlapping spatiotempo-
ral fashion as schematically presented for the E13.5
embryo in Figure 9. This segregated expression is
already present at the olfactory placode stage (E9.5).
The olfactory placodes, which give rise to the vomer-
onasal, olfactory, and respiratory epithelia (Treloar
et al., 2010) are the primary source of progenitors for
three different neuronal lineages—the ORN, VRN,
and GnRH neurons that are essential for feeding, sex-
ual development and reproduction, and social interac-
tion (Tucker et al., 2010). The pioneer ORN and
VRN and the GnRH neurons are born and become
postmitotic during the stages of “primary” neurogen-
esis (E9.5–E12.5); the VNO is also formed during
this period (Kawauchi et al., 2004; Beites et al.,
2005; Ikeda et al., 2007; Tucker et al., 2010). At
these initial stages of peripheral olfactory develop-
ment, the identity of the ORN, VRN, and GnRH neu-
rons is thought to be established through complex E/
M interactions mediated by morphogenetic factors
like all-trans RA. Fgf8 and BMP4, which define the
expression levels and boundaries of a number of tran-
scription factors like Meis1, Sox2 and the neurogenic
bHLH Mash1 (Ascl1), Ngn1, and NeuroD (Rawson
et al., 2010; Tucker et al., 2010).
Figure 9 Schematic presentation of GAD65, GAD67, and
GnRH expression in the nasal region of the E13.5 embryo.
GAD65 is confined to the proliferative basal/apical layer(s)
of the OE and VNE. Based on their position and properties,
GAD651 cells correspond to ORN/VRN progenitors. The
receptor neurons of the VNO (in green) reside in the middle
zone of the epithelium sending axons in the VNN. GAD67
transcribed from the Gad1 gene is expressed in a region of
the ventral VNO and a population of GnRH neurons. Since
the expression of GAD67 in samples collected from tissue
biopsy of migrating GnRH1 neurons or whole septum is
low, GAD44 is the predominant form expressed by the
GAD1 cells in the nasal compartment. GnRH1 (red),
GAD671(yellow), and GnRH1/GAD671 (orange) neu-
rons migrate towards the basal forebrain along the VNN
with a major branch turning caudally toward the ventral
forebrain (nervus terminalis). Receptor neurons of the OE
(green) with their bodies positioned in the middle zone pro-
ject to the main olfactory bulb do not express GAD or
GABA. GAD651 (but GABA2) ORN/VRN progenitors
(blue) occupy predominantly the basal layer of the OE/
VNE. The remote portion of the RE is devoid of GAD
expression. The color code for different cell lineages is
indicated. OE, olfactory epithelium; RE, respiratory epithe-
lium; VNO, vomeronasal organ; CP, cribriform plate.
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Of the two Gad genes, only GAD67 is expressed
in the olfactory placode (E9.5), while both genes are
detectable in the olfactory pit (E10.5–E11.5) where
their expression domains partially overlap, but not at
the cellular level (data not shown). At E11.5–E12.5,
the region of GAD67 expression encompassing a por-
tion of the VNO/pit and adjacent RE essentially over-
laps with the expression domain of Fgf8 and Dlx1&2
(Merlo et al., 2007) (Figs. 4 and 9; Allen Brain
Atlas). This expression pattern is faithfully repro-
duced by GFP in the GAD67-GFP KI embryos. Inter-
estingly, GAD67 like Fgf8 is expressed in the apical
ectodermal ridges (Maddox and Condie, 2001), a
region sharing similar morphogenetic mechanisms
suggesting the involvement of GAD67 and GABA in
E/M transitions (Hagiwara et al., 2003). In chicken,
the GnRH phenotype is induced by Fgf8 (Sabado
et al., 2012) and the hypomorphic Fgf8 mouse mutant
has disrupted VNO morphogenesis and absence of
GnRH neurons (Tucker et al., 2010). This strongly
suggests that the RE/VNO domain of E11.5–E12.5
embryos marked by GAD67 (and Fgf8) expression
overlaps with the initial pool of GnRH progenitors.
In E12.5–E13.5 GAD65 KO, many GnRH1 neurons
could be traced outmigrating from this site before
joining the VNN axons. These observations serve as
additional evidence in support of the notion that post-
mitotic GnRH neurons originally arise and migrate
from the nonsensory RE (Wray, 2010; Forni and
Wray, 2012) and that GAD67 can serve as an early
identification marker for their progenitors. An inde-
pendent and useful label for early GnRH neurons
migrating from the NSE is afforded by GFP in
GAD65_2e/gfp and GAD65_1e-6e/gfp transgenic
embryos, in which a separate migratory stream
emerging from the RE similar to that observed in the
chicken and in the AP-2 KO mouse (Wray, 2010)
was also detected.
In contrast to GAD67, which continues to be
expressed in the GnRH lineage, GAD65 is progres-
sively silenced after E10.5 and becomes virtually
undetectable at the end of primary neurogenesis
(E12.5). It is induced again at E13.5 exclusively in
the sensory OE/VNE. At stages >E12.5, the ORNs
are generated through a secondary wave of neurogen-
esis, whereby proliferative cells residing in the apical
and basal layers of the pseudostratified OE give rise
to either sustentacular cells or ORN/VRN, respec-
tively, and this type of “established” neurogenesis is
uniquely preserved throughout life (Beites et al.,
2005; Ikeda et al., 2007) and references therein). Pre-
vious extensive studies have demonstrated that the
ORNs differentiate from Sox21 olfactory neural
stem cells, which initially proliferate at the apical
surface (Gokoffski et al., 2011; Rosenbaum et al.,
2011) then move to and proliferate at the basal sur-
face of the embryonic OE. Subsequently cells of the
basal layer undergo a temporal differentiation pro-
gram similar to that of other neuroepithelia of the
CNS regulated intrinsically by a cascade of sequen-
tially induced transcription factors—Ascl1, Ngn1,
and NeuroD (Gokoffski et al., 2011; Rosenbaum
et al., 2011).
Gad2 has binding sites for and shows a similar
expression to Mash1 (Ascl1) in both apical and basal
layers at earlier stages (E12.5–E14.5) of OE develop-
ment and is restricted to the basal layer at later stages
(E15.5–P0). Similar to Mash1 and Ngn1, GAD65
was never detected in nascent or terminally differen-
tiated ORNs. Interestingly, Mash1 is known to deter-
mine the GABAergic cell fate, while Ngn1 and
NeuroD abrogate Mash1 action in neuronal progeni-
tors of the ganglionic eminence (Lee et al., 2008;
Roybon et al., 2010). Gad2 gene has a high-score
binding site for the insulinoma-associated protein 1
(Insm1), a Zn-finger transcription factor downstream
of Mash1 that has been implicated in regulating cell
cycle arrest in proliferating cortical (Lan and Breslin,
2009) and OE (Rosenbaum et al., 2011) progenitors
prompting the suggestion that the smaller GAD form
may play a role in the progressive exit from the cell
cycle and transition to neuronal fate during olfactory
sensory neuronal fate determination. This notion
gains an additional support by previous findings
showing that GABA acting on GABAAR inhibits the
proliferation of PSA-NCAM1 neural progenitors of
postnatal striatum (Nguyen et al., 2003) and/or cell-
cycle reentry of neural stem cells in the subventricu-
lar zone (SVZ) (Liu et al., 2005).
The characteristic “patchy” expression of GAD65
in the basal VNE and OE, especially at E15.5 and
later stages is highly reminiscent to that of Mash1
and Ngn1 and some guidance molecules involved in
intercellular signaling and establishing the correct
topographic projection map like Slit2/Robo (Cariboni
et al., 2012), Sema3a (Cariboni et al., 2011), or
Eph5A-ephrin (Gamble et al., 2005; Cariboni et al.,
2012), although its exact role in the process is
unknown. Interestingly, we failed to detect GABA in
the GAD651 cells of the SE suggesting they do not
accumulate the neurotransmitter, but rather it may be
released as soon as it is synthesized acting locally in
an autocrine/paracrine fashion to modulate short-
range intercellular interactions, through activating
GABAR and intracellular Ca21 signaling.
The two Gad genes are regulated in a spatially and
temporally strictly segregated manner, in sharp con-
trast with the GABAergic neurons of the CNS, where
GAD Regulation in the Developing Olfactory System 17
Developmental Neurobiology
they co-localize from early developmental stages
(Katarova et al., 2000). There is also a clear func-
tional segregation between the two forms as GAD67
associates with migratory cells, while GAD65 with
cells undergoing their final proliferative stages.
Similar to the developing CNS (Szabo et al., 1994)
GAD67 and its embryonic splice variants EGAD are
sequentially induced during GnRH neuronal migra-
tion and differentiation as only EGAD is expressed in
the VNO, while GAD67 is induced and progressively
upregulated in the GnRH at later migratory stages, a
tendency also preserved in the immortalized cell lines
GN11 and GT1–7. Notably, EGAD is the predomi-
nant GAD form in the GnRH of the nasal septum.
Interestingly, Dlx2&5, positive regulators of GAD
are also subjected to migratory stage-specific
dynamic regulation, which may suggest that GAD67
splice forms are regulated by different combinations
of Dlx1–6 during migration.
GABA is clearly detectable by IHC in migrating
GnRH and the immortalized cell lines GN11 and
GT1–7 showing a prominent cytoplasmic staining at
the NFJ and GN11, which is weakened and more dif-
fused at later stages and in GT1–7 concomitant with
the increase of GAD67 expression. This indicates
that the dynamic regulation of different GAD forms
during GnRH migration is accompanied by changes
in the intracellular accumulation and/or release of
GABA.
It has been shown that GABA exerts an excitatory
action and regulates the pulsatile GnRH release until
puberty (Han et al., 2002; Heger et al., 2003). GnRH
and GAD are oppositely regulated following dissoci-
ation of GnRH neurons from nervus terminalis such
as GnRH is upregulated while GAD is gradually
turned off at puberty (Heger et al., 2003). Concomi-
tantly, GABA effect exerted through GABAAR on
GnRH neurons switches from depolarizing to hyper-
polarizing and inhibiting GnRH secretion around
postnatal day 31 (Han et al., 2002).
An important aspect of the dynamic regulation of
EGAD and GAD67 during GnRH migration are the
distinct functions EGAD and GAD67 may exert
through specific intracellular GABA pools (Szabo
et al., 1994; Varju et al., 2001). The truncated
GAD44 is regulated at the posttranscriptional level
and its recombinant counterpart displays a high spe-
cific activity in vitro (Szabo et al., 1994). It is local-
ized near the cellular membrane and proximal
processes in GN11 and GT1–7 as in differentiating
neurons (Varju et al., 2002) and its forced expression
alters cell adhesion both in vitro and in vivo (data not
shown). Conversely, GAD67 shows a more wide-
spread distribution in cell bodies and distal neurites
(Varju et al., 2002). We have suggested that GABA
produced by GAD44 is released through a reversal of
the membrane GABA transporter GAT-1 and acts as
an autocrine/paracrine factor via nonsynaptic
GABAR, while GAD67 synthesizes the synaptic
vesicular GABA released at inhibitory synapses and/
or growth cones (Szabo et al., 1994; Varju et al.,
2001; Varju et al., 2002; Kanaani et al., 2010).
The migratory route of GnRH neurons consists of
an early (septo-nasal) and late (NFJ and FB) phases
(Bless et al., 2005), which differ profoundly in migra-
tory features. The early nasal stage is a prototype of
an axophilic migration dependent on GnRH/axonal
interactions mediated by a variety of adhesion mole-
cules, diffusable factors and guidance cues, both
extracellular and membrane-bound (Tobet and
Schwarting, 2006; Cariboni et al., 2007; Wray, 2010;
Wierman et al., 2011; Messina and Giacobini, 2013)
The initially slow saltatory migration of GnRH in the
FNM characterized by predominant EGAD expres-
sion is followed by much faster movements and turn-
ing effects at the NFJ (Bless et al., 2005; Casoni
et al., 2012), which correlate with upregulation of
GAD67. As previously shown, overexpression of
GAD67 using GnRH promoter does not substantially
affect the speed of migration in the FNM, but rather
alters the direction of migration in the FB causing
straying of GnRH to noncanonical brain regions
(Heger et al., 2003). Altogether these findings suggest
that GAD67-produced GABA may act predominantly
to promote directional navigation, while GABA syn-
thesized by EGAD (GAD44) may modulate the speed
of migration, thus the two forms cooperatively regu-
late the precision (speed and timing) of migration.
This effect could be achieved through differential uti-
lization of local GABAAR-evoked Ca
21 signaling
and remodeling of the cytoskeleton (Hutchins et al.,
2013).
The availability of both GAD65 and GAD67 KO
mouse strains (Condie et al., 1997; Kash et al., 1997;
Tamamaki et al., 2003; Yamamoto et al., 2004; Kubo
et al,2009) allows the direct testing of the proposed
roles for different GADs in the GnRH neuronal
migration. Previously, it has been shown that deletion
of GAD67 results in an increased motility of GnRH
through the FNM, moderate increase of GnRH num-
bers at the NFJ of E12.5 and significant increase in
E14.5 GAD67 KO embryos (Lee et al., 2008). Our
analysis showed increased GnRH numbers in the
FNM and NFJ at E12.5, but decreased numbers at
E14.5 in both GAD65 KO and GAD67-GFP KI
embryos clearly indicating the complementary role of
the two Gad genes in the regulation of GnRH migra-
tion. The discrepancies between our data and these of
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Lee et al. (2008) concerning E14.5 embryo may be
explained by differences in the strains used for the
two studies and/or substantial variations among indi-
vidual GAD67KO embryos (Lee et al., 2008).
The statistically significant increase in the number
of migratory GnRH neurons in E12.5 (but not E14.5)
embryos with a deletion of GAD65 is peculiar as this
form is not expressed in the GnRH lineage or differ-
entiated VRN whose axons provide the substrate for
axophilic migration. It demonstrates the primarily
inhibitory role of GAD65 on the differentiation and
acquirement of migratory properties of the “early”
GnRH pool delaminating from the pit during stages
of “primary” neurogenesis. The appearance of
numerous GnRH1 neurons on the territory of the
NSE of GAD65 KO embryos is in support of this
conclusion, albeit the underlying mechanisms are
still unknown. It should be stressed, that the adult
GAD65 mice of both sexes have a normal onset of
puberty, but are infertile, although the underlying
causes were not persued in this study. In agreement
with previous data, GAD67 deletion has a small
impact on the total number of migrating GnRH at
this embryonic stage (Lee et al., 2008).
In E14.5 embryos, GnRH1 cell numbers from differ-
ent parts of the migratory route as well as the total
GnRH numbers of both GAD65 KO or GAD67-GFP KI
are reduced, but not significantly indicating the exist-
ance of compensatory mechanisms (Lee et al., 2010).
Surprisingly, our studies in double GAD65/
GAD67 KO mouse embryos revealed that the GnRH
expression is not dramatically affected in these mice,
as there is only a subtle change in migratory GnRH1
cell numbers compared to the respective single GAD
KO mice (data not shown). Previous results in our
laboratory have shown that GAD67-GFP KI and the
GAD65/67 double KO express a novel alternatively
spliced message and increased level of embryonic
GAD44 protein (data not shown), which may be
responsible for the synthesis of residual GABA in
this mutant (Ji et al., 1999) and a partial rescue during
early and mid-gestation embryonic stages, which
have been the focus of this study.
The most apparent change in the double mutant is
the abnormal GnRH cell aggregation especially at the
NFJ. The effect was seen also in the GAD67-GFP KI
mutants, but to a lesser extent, which clearly points to
the contribution of GAD65-mediated GABA signal-
ing, possibly through delayed effect on the VNN
axons. The precise spatiotemporal migration of the
GnRH neurons is critically dependent on their proper
guidance by the VNN axons and mediated by a variety
of cell signaling molecules like ephrins, semaphorins
and their receptors, which similar to the GAD forms
are differentially expressed and dynamically regulated
along the GnRH migratory route (Cariboni et al.,
2011; Messina and Giacobini, 2013) or cause abnor-
mal clumping of GnRH neurons in the FNM at altered
expression levels (Gamble et al., 2005) suggesting a
possible interplay with the GABA signalling.
Excessive GnRH/GnRH aggregation may result
from weakened interactions between leading/trailing
processes of GnRH and VRN axons due to GAD67
deficiency under conditions of stronger GnRH adhe-
sion at the cellular membrane in the presence of
GAD44 that may be mediated by distinct intracellular
GABA pools. Consistent with this is the observed
increased aggregation at NFJ compared to the FNM
region correlating with the increased contribution of
GAD67 at later migratory stages. As previously
shown, GABA can mediate changes in adhesion
properties through direct binding of GABAAR to cell
adhesion and/or cytoskeletal proteins (Wang and
Olsen, 2000; Zhang et al., 2010). An increased cell
adhesion/gap junction coupling through GABAAR-
evoked activation of intracellular Ca21 signaling has
recently been demonstrated for mouse ES cells
(Schwirtlich et al., 2010).
In conclusion, our results demonstrate that GAD67
and GAD65 display a nonoverlapping expression and
nonredundant roles in two cell lineages of distinct
origin and fate: the migratory GnRH neurons origi-
nating in the NSE and ORN/VRN progenitors con-
fined to the proliferative layers of the sensory OE/
VNE (Fig. 9). This clear association of GAD65 and
GAD67 in the developing olfactory region with a
“proliferative” and “migratory” cellular responses
may have a broader significance in and outside the
CNS that should allow for a precise determination of
the special roles of different GADs and downstream
components in the GABAergic differentiation.
Finally, our data also suggest that GAD65,
GAD67, and EGAD act through distinct subcellular
GABA pools and may activate selectively down-
stream signaling cascades to conjointly contribute to
the precise timing of migration, arrival and ultimately
positioning of GnRH in the hypothalamus.
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